Japan· JP-2399407G4023
ミリキズマブ（遺伝子組換え）
A medicinal product containing ミリキズマブ（遺伝子組換え）, registered in Japan by 日本イーライリリー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ミリキズマブ（遺伝子組換え）
- Manufacturer
- 日本イーライリリー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ミリキズマブ（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOMVOHEli Lilly Nederland B.V., Utrecht
- United StatesOmvohEli Lilly and Company
- FinlandOmvohAbacus Medicine A/S
- BelgiumOmvoh 100 mgEli Lilly Nederland
- SwitzerlandOmvoh 100 mg + 200 mg, solution injectable en seringue préremplieEli Lilly (Suisse) SA
- SwedenOmvoh 100 mg + 200 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- NetherlandsOmvoh 100 mg + 200 mg oplossing voor injectie in een voorgevulde penEli Lilly Nederland B.V.
- IcelandOmvohEli Lilly Nederland B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Omvoh
- Liechtenstein · Omvoh
- Norway · Omvoh
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b23f4e53-bddd-44c4-9279-a488f272a8bd GET /v1/drugs/b23f4e53-bddd-44c4-9279-a488f272a8bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ２ｍＬ１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2399407G4023",
"category": "注射薬",
"price_yen": 241157,
"generic_name": "ミリキズマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2399",
"transitional_expiry": null
}See everything about ミリキズマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.